The 12th Alzheimer`s and Parkinson`s Drug Development Summit is dedicated to CNS Biopharma to Revolutionize the Next Wave of Neurodegenerative Therapeutics.
The 12th Alzheimer`s and Parkinson`s Drug Development Summit covers topics such as:
- Novel modelling methods to bolster recapitulation of the CNS
- Fortifying the neurodegenerative field: strategic positioning of future pipelines
- Biology & beyond – understanding the fundamentals to map future pathological targets in alzheimer’s
- Mapping clinical study design for efficient timelines in high investment neurodegenerative trials
- Restoring confidence & progressing trust for future neurodegenerative drug development
- Upcoming applications in alzheimer’s disease – varying strategies to approach successful treatment
- The spectrum of technologies employed to boost neuro-discovery
- Tackling the multiple approaches to degenerative disease & enriching modern development tactics
